Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera

Molecular Medicine

Volumn 17, Issue 11, 2011, Pages 1338-1348

  Chu, Charles C ^a,b,c   Zhang, Lu ^a   Dhayalan, Arjun ^a   Agagnina, Briana M ^a   Magli, Amanda R ^a   Fraher, Gia ^a   Didier, Sebastien ^a   Johnson, Linda P ^a   Kennedy, William J ^a   Damle, Rajendra N ^a,c   Yan, Xiao Jie ^a   Patten, Piers E M ^a   Teichberg, Saul ^b   Koduru, Prasad ^b,d   Kolitz, Jonathan E ^a,b,c   Allen, Steven L ^a,b,c   Rai, Kanti R ^a,c,e   Chiorazzi, Nicholas ^a,b,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA FRAGMENT; GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN KINASE ZAP 70;

AGED; ANALYTIC METHOD; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENOME AMPLIFICATION METHOD; GENOTYPE; HUMAN; IGHV GENE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYCYTHEMIA VERA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; TORQUE TENO VIRUS; VIRUS GENOME; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS REPLICATION;

AGED; AGED, 80 AND OVER; BLOOD DONORS; CASE-CONTROL STUDIES; DNA VIRUS INFECTIONS; DNA, VIRAL; FEMALE; GENOME, VIRAL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYCYTHEMIA VERA; REPRODUCIBILITY OF RESULTS; TORQUE TENO VIRUS;

EID: 82855164041     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00110     Document Type: Article

References (53)

1. Javier RT, Butel JS. (2008) The history of tumor virology. Cancer Res. 68:7693-706.
2. Ziegler JL, Buonaguro FM. (2009) Infectious agents and human malignancies. Front. Biosci. 14:3455-64.
3. Chu CC, et al. (2007) Plasma from a B-cell chronic lymphocytic patient with polycythemia vera contains viral and bacterial DNA. In: 13th International Congress of Immunology. Kalil J, Cunha-Neto E, Rizzo LV (eds.). Medimond S.r.l., Monduzzi Editore, Bologna, Italy, pp. 589-95.
4. Fais F, et al. (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1515-25.
5. Damle RN, et al. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1840-7.
6. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1848-54.
7. Murray F, et al. (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood. 111:1524-33.
8. Hamblin T. (2006) Is chronic lymphocytic leukemia a response to infectious agents? Leuk. Res. 30:1063-4.
9. Zucca E, Bertoni F, Stathis A, Cavalli F. (2008) Marginal zone lymphomas. Hematol. Oncol. Clin. North Am. 22:883-901, viii.
10. Landgren O, et al. (2006) Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood. 108:292-6.
11. Landgren O, et al. (2007) Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. 109:2198-201.
12. Mann DL, et al. (1987) HTLV-I: associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science. 236:1103-6.
13. Dolcetti R, Carbone A. (2011) Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor? Infect. Agent. Cancer. 5:22.
14. Flynn JM, Andritsos L, Lucas D, Byrd JC. (2010) Second malignancies in B-cell chronic lymphocyticleukaemia: possible association with human papilloma virus. Br. J. Haematol. 149:388-90.
15. Teman CJ, Tripp SR, Perkins SL, Duncavage EJ. (2011) Merkel cell polyomavirus (MCPyV) in chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk. Res. 35:689-92.
16. Chumak AA, et al. (2010) Persistent infections and their relationship with selected oncologic and non-tumor pathologies. J. Immunotoxicol. 7:279-88.
17. Gillet N, et al. (2007) Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology. 4:18.
18. Levy J, et al. (2008) 2008 American Association of Feline Practitioners' feline retrovirus management guidelines. J. Feline Med. Surg. 10:300-16.
19. Depil S, Roche C, Dussart P, Prin L. (2002) Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia. 16:254-9.
20. Tefferi A. (2007) JAK2 mutations in polycythemia vera: molecular mechanisms and clinical applications. N. Engl. J. Med. 356:444-5.
21. Moreau-Gachelin F. (2008) Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation. Retrovirology. 5:99.
22. Wang G, Ahn YS, Whitcomb CC, Harrington WJ. (1984) Development of polycythemia vera and chronic lymphocytic leukemia during the course of refractory idiopathic thrombocytopenic purpura. Cancer. 53:1770-6.
23. Hussein K, et al. (2006) B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2. Eur. J. Haematol. 77:539-41.
24. zur Hausen H, de Villiers EM. (2005) Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas. Int. J. Cancer. 115:1-5.
25. Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D. (2004) The New York Cancer Project: rationale, organization, design, and baseline characteristics. J. Urban Health. 81:301-10.
26. Ghiotto F, et al. (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J. Clin. Invest. 113:1008-16.
27. Damle RN, et al. (2007) CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells. Blood. 110:3352-9.
28. Rassenti LZ, et al. (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood. 112:1923-30.
29. Baxter EJ, et al. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 365:1054-61.
30. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. (1998) Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol. Res. 12:233-9.
31. Swerdlow SH, et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. Lyon: IARC. 439 pp.
32. Biagini P. (2009) Classification of TTV and related viruses (anelloviruses). Curr. Top. Microbiol. Immunol. 331:21-33.
33. Okamoto H. (2009) History of discoveries and pathogenicity of TT viruses. Curr. Top. Microbiol. Immunol. 331:1-20.
34. Carstens EB. (2010) Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2009). Arch. Virol. 155:133-46.
35. Maggi F, Bendinelli M. (2010) Human anelloviruses and the central nervous system. Rev. Med. Virol. 20:392-407.
36. Itoh Y, et al. (2000) Visualization of TT virus particles recovered from the sera and feces of infected humans. Biochem. Biophys. Res. Commun. 279:718-24.
37. Handa A, Dickstein B, Young NS, Brown KE. (2000) Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion. 40:245-51.
38. Kakkola L, Hedman K, Qiu J, Pintel D, Soderlund-Venermo M. (2009) Replication of and protein synthesis by TT viruses. Curr. Top. Microbiol. Immunol. 331:53-64.
39. Schat KA. (2009) Chicken anemia virus. Curr. Top. Microbiol. Immunol. 331:151-83.
40. Wiestner A, et al. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 101:4944-51.
41. Shiramizu B, Yu Q, Hu N, Yanagihara R, Nerurkar VR. (2002) Investigation of TT virus in the etiology of pediatric acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 19:543-51.
42. Cacoub P, et al. (2003) Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma. Clin. Microbiol. Infect. 9:39-44.
43. Zhong S, et al. (2001) Gross elevation of TT virus genome load in the peripheral blood mononuclear cells of cancer patients. Ann. N. Y. Acad. Sci. 945:84-92.
44. Garbuglia AR, et al. (2003) Detection of TT virus in lymph node biopsies of B-cell lymphoma and Hodgkin's disease, and its association with EBV infection. Int. J. Immunopathol. Pharmacol. 16:109-18.
45. Leppik L, et al. (2007) In vivo and in vitro intragenomic rearrangement of TT viruses. J. Virol. 81:9346-56.
46. Kato T, et al. (2000) Development of a TT virus DNA quantification system using real-time detection PCR. J. Clin. Microbiol. 38:94-8.
47. Levine RL, et al. (2005) The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia. Blood. 106:3377-9.
48. Ishii T, Bruno E, Hoffman R, Xu M. (2006) Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera. Blood. 108:3128-34.
49. Larsen TS, Christensen JH, Hasselbalch HC, Pallisgaard N. (2007) The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders. Br. J. Haematol. 136:745-51.
50. Delhommeau F, et al. (2007) Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis. Blood. 109:71-7.
51. Eskazan AE, Salihoglu A, Diz-Kucukkaya R, Hancer VS, Soysal T. (2011) Chronic lymphocytic leukemia developing in a patient with Janus kinase 2 V617F mutation positive myeloproliferative neoplasm. Ann. Hematol. 2011, May 17 [Epub ahead of print].
52. Kodali S, Chen C, Rathnasabapathy C, Wang JC. (2009) JAK2 mutation in a patient with CLL with coexistent myeloproliferative neoplasm (MPN). Leuk. Res. 33:e236-9.
53. Lefranc MP, et al. (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37:D1006-12.